About Us

 

Our work spans over 15 years of scientific discoveries, from preclinical asthma models to translational research, and clinical trials. Our goal is to improve the lives of those suffering from chronic diseases.

Macrophage Therapy is a novel approach aimed at treating patients with asthma using autologous monocyte-derived macrophages from which PLA2G5, a key regulator of inflammation, has been removed using CRISPR technology.

Our ultimate objective is to enhance transplantation therapy to cure chronic diseases, including asthma.